Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2008
03/13/2008US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea
03/13/2008US20080064715 I kappa B kinase inhibition; diabetes; (7-Chloro-1H-pyrrolo[2,3-c]pyridin-2-yl)methanol; N-Benzyl-7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide
03/13/2008US20080064701 Controlling blood glucose levels in type 2 diabetic patients with dipeptidyl peptidase-4 proteolytic activity inhibitor and biguanide slow release medicant
03/13/2008US20080064697 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis
03/13/2008US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors
03/13/2008US20080064691 Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/13/2008US20080064683 Oral or intraveinous administration of 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; ELISA analysis; angiogenesis inhibitors; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration
03/13/2008US20080064676 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity
03/13/2008US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3
03/13/2008US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses
03/13/2008US20080064658 Use of Isomaltooligosaccharides to Decrease Abdominal Fat
03/13/2008US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis
03/13/2008US20080064632 Combination Therapy for the Treatment of Obesity
03/13/2008US20080063726 Micronized fenofibrate; polyvinylpyrrolidone, polyvinyl alcohol, hydroxypropylcellulose hydrophilic polymer; sodium lauryl sulfate, monooleate, monolaurate, monopalmitate surfactant; starch, colloidal silica, cross-linked polyvinyl pyrrolidone inert hydrosoluble carrier particles; hypolipemiant
03/13/2008US20080063625 Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture
03/13/2008CA2663100A1 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
03/13/2008CA2663091A1 Modulators of interleukin-1 receptor-associated kinase
03/13/2008CA2662710A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation
03/13/2008CA2662682A1 Agent for prevention or treatment of blood glucose level elevation
03/13/2008CA2662084A1 Combination treatment for diabetes mellitus
03/13/2008CA2661975A1 Benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger
03/13/2008CA2661404A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
03/12/2008EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same
03/12/2008EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
03/12/2008EP1897880A1 1,3-benzothiazinone derivative and use thereof
03/12/2008EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
03/12/2008EP1897872A1 Activator for peroxisome proliferator-activated receptor
03/12/2008EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
03/12/2008EP1897558A1 Solid preparation
03/12/2008EP1897547A1 Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
03/12/2008EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid
03/12/2008EP1897541A2 Hypoglycemic agent
03/12/2008EP1897539A1 Anti-fatigue composition
03/12/2008EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor
03/12/2008EP1896489A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
03/12/2008EP1896485A1 Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
03/12/2008EP1896460A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
03/12/2008EP1896459A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896458A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
03/12/2008EP1896445A1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
03/12/2008EP1896435A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
03/12/2008EP1896418A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators
03/12/2008EP1896410A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896409A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
03/12/2008EP1896408A1 New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
03/12/2008EP1896407A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
03/12/2008EP1896396A1 Anthranilic acid derivatives
03/12/2008EP1896135A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
03/12/2008EP1896082A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
03/12/2008EP1896077A2 Methods and compositions for the prevention and treatement of inflammatory disease
03/12/2008EP1896049A1 Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
03/12/2008EP1896011A1 New use
03/12/2008EP1896003A2 Parenteral selenomethionine for production of selenium-rich foods
03/12/2008EP1641799B1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
03/12/2008EP1617832B1 Compositions for affecting weight loss
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/12/2008EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/12/2008EP1411986B1 Composition comprising epigallocatechin gallate
03/12/2008EP1404675B1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
03/12/2008EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
03/12/2008EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
03/12/2008CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
03/12/2008CN101142215A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
03/12/2008CN101142201A Substituted phenyl-piperazine compounds, their preparation and use in medicaments
03/12/2008CN101141997A Cooperation thermal stabilization oil medium containing eicosapentaenoic acid(EPA) and docosahexenoic acid
03/12/2008CN101141974A Protein introducing carrier, protein introducing agent given by using the carrier, method for introducing the protein, protein introduced cell, and method for producing the cell
03/12/2008CN101141964A Methods and compositions for treating diabetes, metabolic syndrome and other conditions
03/12/2008CN101139569A alpha-amylase inhibitor production bacterium and method for preparing alpha-amylase inhibitor and application
03/12/2008CN101139557A Lactobacillus casei and its application for improvement of blood lipid metabolism and immunological regulation
03/12/2008CN101139554A Solid-state fermentation preparing method for Chinese herbal medicine yeast selenium
03/12/2008CN101139393A KDR peptides and vaccines containing the same
03/12/2008CN101139392A KDR peptides and vaccines containing the same
03/12/2008CN101139345A Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
03/12/2008CN101139306A Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
03/12/2008CN101139281A Nano calcium lactate and method for making same
03/12/2008CN101139280A Sodium acetate anhydrous and preparation method and usage thereof
03/12/2008CN101138609A Prescription of Chinese yam lozenge
03/12/2008CN101138582A Use of compound red sage root tablet for producing medicine for preventing and treating diabetes chronic complication
03/12/2008CN101138578A Application of eucommia lignans and extract thereof in the preventing and controlling of diabetes complication
03/12/2008CN101138577A Lipoic acid health food and uses thereof
03/12/2008CN101138570A Multiple vitamin and mineral composition chewing tablet
03/12/2008CN101138568A Application of hydrochloric acid in the preparation of medicament for treating diabetes and prostate gland disease
03/12/2008CN101138567A Natural glycosides component having good effect of reducing blood sugar
03/12/2008CN101138549A Mitiglinide calcium self-microemulsifying drug delivery system
03/12/2008CN101138420A Application of hypericum seniawinii maxim in the producing of food products for improving memory of learning
03/12/2008CN101138374A Cortex encomia bag tea particles and method of preparing the same
03/12/2008CN100374534C Method for recovering phytosterol form by-product of vegetable oil refining
03/12/2008CN100374466C Antibodies against human IL-12
03/12/2008CN100374465C Neutralizing antibodies against GDF-8 and uses therefor
03/12/2008CN100374462C Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use
03/12/2008CN100374461C Glucagon-like peptide-2 and its therapeutic use
03/12/2008CN100374440C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
03/12/2008CN100374439C Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors
03/12/2008CN100374434C Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives
03/12/2008CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
03/12/2008CN100374416C P-(sulfonyl)-aryl and heteroaryls amines
03/12/2008CN100374155C Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 1298